Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
29%
ALSO IN PPH
PPH
27
HOLDINGS
21%
ALSO IN THNR
SECTOR DRIFT (THNR minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.8% | 22.3% | 13.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 14.6% | 5.9% | 5.9% |
|
MERCK & CO. INC. | 4.9% | 9.5% | 4.9% |
|
PFIZER INC | 4.7% | 4.8% | 4.7% |
|
ABBVIE INC | 4.7% | 4.1% | 4.1% |
THNR Overweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | 8.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 6.0% |
|
AMGEN INC | 6.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.4% |
|
REGENERON PHARMACEUTICALS | 5.4% |
 |
INNOVENT BIOLOGICS, INC. | 5.0% |
 |
ASTRAZENECA PLC | 4.6% |
|
SHIONOGI & CO LTD | 4.1% |
 |
CHINA PHARMACEUTICAL GROUP | 4.1% |
|
SCHOLAR ROCK HOLDING CORP. | 2.3% |
THNR Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.5% |
|
ELI LILLY & CO | -8.5% |
|
MERCK & CO. INC. | -4.6% |
|
BRISTOL-MYERS SQUIBB CO | -4.3% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.2% |
|
ASTRAZENECA PLC-SPONS ADR | -4.1% |
|
JOHNSON & JOHNSON | -4.0% |
|
MCKESSON CORP | -3.6% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.3% |